| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |